U.S. FDA advisers back Pfizer arthritis drug
WASHINGTON (Reuters) – Pfizer Inc won a U.S. advisory panel’s support on Wednesday for its arthritis drug
Tag Archives: fda
FDA staff question Pfizer arthritis drug benefits
WASHINGTON (Reuters) – U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc’s experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections
Fighting cellulite with lasers
Dr. Sanjay Gupta reports on Cellulaze, a new FDA-approved procedure some say may be a long-term solution to cellulite
FDA advisers back HeartWare blood pump device
WASHINGTON (Reuters) – HeartWare International Inc won a U.S. advisory panel’s support on Wednesday for its most important product — a blood pump that helps people with severe heart failure
Study: Teen access to Plan B uneven
Since 2009 the Food and Drug Administration (FDA) has mandated that Plan B and other emergency contraceptives be available without a prescription to women age 17 and up. In reality, a new study suggests, a 17-year-old’s access to these drugs can be uncertain
Recent Comments